November 2024 brought promising clinical trial results, including a new CAR-T therapy showing high remission rates in relapsed …
In 2024, the European Medicines Agency (EMA) recommended a record 114 new medicines for approval, showcasing major advances …
Clinical research in 2024 is progressing rapidly, driven by pioneering studies, technological innovation, and evolving regulatory frameworks that …
Clinical research worldwide is rapidly transforming through new digital strategies—especially in the field of rare diseases. Recent months …
Leading biopharma firms are harnessing AI-driven collaborations to accelerate drug discovery and deliver transformative healthcare solutions.
Advanced manufacturing technologies are transforming biopharma production lines, driving efficiency, quality, and scalability to meet growing global demand.
Cutting-edge biomarker technologies are enabling faster, more accurate cancer diagnosis and tailored therapies, revolutionizing precision oncology.
With a blockbuster IPO on the horizon, Australian biotech innovation is drawing global eyes and fresh capital to …
With a first-in-class oral treatment approved, atopic dermatitis patients gain a novel option for disease management and improved …